Sunshine Lake Pharma Co., Ltd.

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

6,353

Website

www.hecpharm.com

Country

China

Exchange

HKSE

Sunshine Lake Pharma develops, manufactures, and sells pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology. It offers Kewei for the treatment of influenza.

Its portfolio also includes Dongweien for the treatment of hepatitis C, and generic drugs for the treatment of infections caused by sensitive bacteria, namely Clarithromycin, Levofloxacin, and Moxifloxacin Hydrochlorid

Active pharmaceutical ingredients, as well as the wholesale, retail, import, and export of drugs. The company was formerly known as Sunshine Lake Pharma Ltd. The company was incorporated in 2001 and is based in Dongguan, China.

Key Stats

52-Week Range

HK$15.01HK$62.30

Beta-0.11

Trailing P/E60.06

Forward P/EN/A

Trailing EPS0.64

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.